- Traditional Medicine > Traditional, Complementary and Herbal Medicine
- Quality and Safety: Medicines > Safety and Efficacy
(1993; 94 pages)
Guidelines for the assessment of herbal medicine programme on traditional medicine. Geneva: World Health Organization, document, 1991 (WHO/TRM/91.4).
Guidelines for reproduction studies for safety evaluation of drugs for human use. Bethesda, MD: U.S. Food and Drug Administration, 1966.
1990 Guidelines for toxicity studies of drugs manual/editorial supervision by New Drugs Division, Pharmaceutical Affairs Bureau, Ministry of Health and Welfare. Tokyo: Yakuji Nippo, 1991.
Guiding principles for clinical research on new drugs (traditional Chinese medicine). Beijing, China: Ministry of Public Health; Bureau of Drug Policy and Administration, 1989.
Proposed WHO guidelines for good clinical practice (GCP) for trials on pharmaceutical products WHO drug information 1992. 6(4) 170-188
Provisions for new drugs approval Beijing, China Ministry of Public Health, 1988.
Provisions for new drug approval: supplementary stipulation and revision of issues related to traditional Chinese medicine, Beijing, China: Ministry of Public Health, 1992.
Selection and scientific validation of medicinal plants for primary health care. Taguig, Metro Manila: Department of Science and Technology, Philippine Council for Health Research and Development, 1991. (Technical report series 12).
Technical guidelines for pharmaceuticals in the European Economic Community, editor, Duilio Poggiolini, New York: Raven Press, 1983.
The rules governing medicinal products in the European community: Volume III. Guidelines on the quality, safety and efficacy of medicinal products for human use, Luxembourg: Office for Official Publications of the European Communities, 1989.